RPAM
Rhenman & Partners Asset Management’s BioMarin Pharmaceuticals BMRN Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $8.23M | Sell |
149,650
-115,350
| -44% | -$6.34M | 1.04% | 37 |
|
|
2025
Q1 | $18.7M | Buy |
265,000
+14,377
| +6% | +$1.02M | 2.15% | 19 |
|
|
2024
Q4 | $16.5M | Sell |
250,623
-113,877
| -31% | -$7.49M | 1.69% | 22 |
|
|
2024
Q3 | $25.6M | Buy |
364,500
+113,000
| +45% | +$7.94M | 2.08% | 19 |
|
|
2024
Q2 | $20.7M | Buy |
251,500
+14,000
| +6% | +$1.15M | 1.99% | 18 |
|
|
2024
Q1 | $20.7M | Sell |
237,500
-45,000
| -16% | -$3.93M | 1.97% | 20 |
|
|
2023
Q4 | $27.2M | Sell |
282,500
-97,500
| -26% | -$9.4M | 2.72% | 8 |
|
|
2023
Q3 | $33.6M | Hold |
380,000
| – | – | 3.63% | 3 |
|
|
2023
Q2 | $32.9M | Buy |
380,000
+155,000
| +69% | +$13.4M | 3.47% | 2 |
|
|
2023
Q1 | $21.4M | Sell |
225,000
-29,000
| -11% | -$2.76M | 2.35% | 18 |
|
|
2022
Q4 | $26.3M | Buy |
254,000
+17,000
| +7% | +$1.76M | 2.74% | 6 |
|
|
2022
Q3 | $20.5M | Buy |
237,000
+97,000
| +69% | +$8.4M | 2.15% | 17 |
|
|
2022
Q2 | $11.6M | Sell |
140,000
-80,000
| -36% | -$6.63M | 1.32% | 30 |
|
|
2022
Q1 | $17M | Sell |
220,000
-45,000
| -17% | -$3.47M | 1.67% | 23 |
|
|
2021
Q4 | $23.6M | Buy |
265,000
+25,000
| +10% | +$2.23M | 1.57% | 20 |
|
|
2021
Q3 | $18.6M | Buy |
240,000
+80,000
| +50% | +$6.18M | 1.3% | 33 |
|
|
2021
Q2 | $13.4M | Sell |
160,000
-20,000
| -11% | -$1.67M | 0.91% | 46 |
|
|
2021
Q1 | $13.6M | Sell |
180,000
-330,000
| -65% | -$24.9M | 0.95% | 43 |
|
|
2020
Q4 | $44.7M | Sell |
510,000
-234,354
| -31% | -$20.6M | 3.65% | 2 |
|
|
2020
Q3 | $56.6M | Buy |
744,354
+554,354
| +292% | +$42.2M | 5.04% | 1 |
|
|
2020
Q2 | $23.4M | Buy |
190,000
+5,155
| +3% | +$636K | 2.53% | 5 |
|
|
2020
Q1 | $15.6M | Sell |
184,845
-25,155
| -12% | -$2.13M | 2.19% | 11 |
|
|
2019
Q4 | $17.8M | Sell |
210,000
-80,491
| -28% | -$6.81M | 1.95% | 13 |
|
|
2019
Q3 | $19.6M | Buy |
290,491
+9,142
| +3% | +$616K | 2.45% | 10 |
|
|
2019
Q2 | $24.1M | Buy |
281,349
+49,800
| +22% | +$4.27M | 2.65% | 10 |
|
|
2019
Q1 | $20.6M | Buy |
231,549
+55,000
| +31% | +$4.89M | 2.41% | 12 |
|
|
2018
Q4 | $15M | Sell |
176,549
-88,300
| -33% | -$7.52M | 1.72% | 22 |
|
|
2018
Q3 | $25.7M | Buy |
264,849
+25,000
| +10% | +$2.42M | 2.57% | 6 |
|
|
2018
Q2 | $22.6M | Buy |
239,849
+35,000
| +17% | +$3.3M | 2.31% | 12 |
|
|
2018
Q1 | $16.6M | Buy |
204,849
+65,000
| +46% | +$5.27M | 2.05% | 19 |
|
|
2017
Q4 | $12.5M | Sell |
139,849
-40,100
| -22% | -$3.58M | 1.69% | 23 |
|
|
2017
Q3 | $16.7M | Sell |
179,949
-9,351
| -5% | -$870K | 2.14% | 12 |
|
|
2017
Q2 | $17.2M | Buy |
189,300
+64,300
| +51% | +$5.84M | 2.47% | 8 |
|
|
2017
Q1 | $11M | Buy |
125,000
+75,000
| +150% | +$6.58M | 1.74% | 20 |
|
|
2016
Q4 | $4.14M | Sell |
50,000
-90,000
| -64% | -$7.46M | 0.79% | 50 |
|
|
2016
Q3 | $13M | Sell |
140,000
-10,000
| -7% | -$925K | 2.06% | 13 |
|
|
2016
Q2 | $11.7M | Sell |
150,000
-40,000
| -21% | -$3.11M | 2.07% | 12 |
|
|
2016
Q1 | $15.7M | Buy |
190,000
+72,000
| +61% | +$5.94M | 3.11% | 3 |
|
|
2015
Q4 | $12.4M | Buy |
118,000
+32,000
| +37% | +$3.35M | 1.87% | 16 |
|
|
2015
Q3 | $9.06M | Sell |
86,000
-6,000
| -7% | -$632K | 1.44% | 28 |
|
|
2015
Q2 | $12.6M | Buy |
92,000
+17,000
| +23% | +$2.33M | 1.51% | 16 |
|
|
2015
Q1 | $9.35M | Buy |
75,000
+14,000
| +23% | +$1.74M | 1.58% | 21 |
|
|
2014
Q4 | $5.51M | Sell |
61,000
-31,000
| -34% | -$2.8M | 1.6% | 20 |
|
|
2014
Q3 | $6.64M | Sell |
92,000
-58,000
| -39% | -$4.19M | 1.94% | 9 |
|
|
2014
Q2 | $9.33M | Buy |
150,000
+4,736
| +3% | +$295K | 2.77% | 7 |
|
|
2014
Q1 | $9.91M | Buy |
145,264
+45,264
| +45% | +$3.09M | 2.97% | 6 |
|
|
2013
Q4 | $7.03M | Buy |
+100,000
| New | +$7.03M | 2.75% | 7 |
|